Drug Interactions between Belladonna Tincture and Sprycel
This report displays the potential drug interactions for the following 2 drugs:
- Belladonna Tincture (belladonna)
- Sprycel (dasatinib)
Interactions between your drugs
No interactions were found between Belladonna Tincture and Sprycel. This does not necessarily mean no interactions exist. Always consult your healthcare provider.
- Belladonna tincture is in the drug class anticholinergics/antispasmodics.
- Belladonna tincture is used to treat the following conditions:
- Sprycel is in the drug class BCR-ABL tyrosine kinase inhibitors.
- Sprycel is used to treat the following conditions:
Drug and food interactions
Applies to: Sprycel (dasatinib)
Do not consume grapefruit or grapefruit juice during treatment with dasatinib. Grapefruit juice can significantly increase the blood levels and effects of dasatinib, which may result in excessive slowing of heart rate or other conduction disturbances and it may affect your bone marrow function, resulting in low numbers of different types of blood cells. You may be more likely to develop anemia, bleeding problems, or infections due to low blood cell counts. Talk to your doctor if you have any questions or concerns. You should seek immediate medical attention if you develop sudden dizziness, lightheadedness, fainting, shortness of breath, heart palpitations, paleness, fatigue, unusual bruising or bleeding, fever, chills, diarrhea, sore throat, muscle aches, blood in phlegm, weight loss, pain or burning during urination, red or inflamed skin, or body sores during treatment with dasatinib. It is important to tell your doctor about all other medications you use, including vitamins and herbs. Do not stop using any medications without first talking to your doctor.
Therapeutic duplication warnings
No warnings were found for your selected drugs.
Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.
Drug Interaction Classification
|Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.|
|Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.|
|Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.|
|No interaction information available.|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.